News 
Contact Us
No. 18, Fuyuan Road, Tianjin Wuqing Development Area, China
Openness and Win-Win Cooperation! Swiss Innovation China Roadshow Held in Wuqing Development Area
On the afternoon of December 9th, the Wuqing Development Area, in collaboration with Succeed Consulting and Panshi Capital, hosted the Swiss Innovation China Roadshow. Representatives from over 10 biomedical enterprises in the area, including Chasesun Pharmaceutical, BMC Medical, Novogene, and Ringpu Bio-Technology, participated in the event and engaged in in-depth discussions with the Swiss Biomedical Delegation to China.
Leveraging innovation resources from prestigious universities such as ETH Zurich and EPFL, as well as technology parks and incubation institutions, Succeed Consulting has gathered a wealth of innovation project resources and entrepreneurial talent. This Swiss Innovation China Roadshow aimed to establish a platform for high-level dialogue and precise matchmaking between the Sino-Swiss biomedical industries, accelerate the clustering of high-quality foreign investment and enterprises in Wuqing, and promote the high-quality development of Wuqing's biomedical sector.
During the meeting, a representative from the Wuqing District Investment Promotion Bureau delivered a special presentation, comprehensively introducing Wuqing District's convenient location and transportation, robust industrial foundation, first-class business environment, and comprehensive policy support system for leading industries such as biomedicine. A sincere invitation for cooperation was extended to Swiss innovative enterprises.
In the roadshow segment, the Swiss Biomedical Delegation to China showcased five cutting-edge innovation projects:
· Alpigen Life Sciences: Developing next-generation in vivo engineered cell therapies
· Incaptek: Smart microcapsules for next-generation controlled and targeted release technology
· Immitra Bio: A scalable platform for gene editing therapeutics
· Nan Thermix SA: Innovative microscale temperature control solutions for electrophysiology
· Flex Enterprise: Safe haptic feedback solutions for medical robotics
Project representatives introduced their respective technological features, market prospects, and collaboration needs, sparking strong interest among the attending enterprises and investment institutions.
Chinese enterprise representatives engaged in in-depth, practical discussions with the Swiss project teams on technical details, industrialization pathways, and cooperation models. Several companies expressed clear intentions for further contact and collaboration on-site. "We are engaged in gene therapy drug development and are very interested in Immitra Bio's innovative project. We look forward to further exchanges to explore entry points for cooperation and achieve mutual success," said a representative from GeneLeap Pharma.
This event not only successfully demonstrated Switzerland's innovation strength in the biomedical field but also clearly conveyed Wuqing District's positive signal of expanding high-standard opening-up and promoting international resource linkage. A representative from the Wuqing Development Area stated that they would take this event as an opportunity to establish a long-term communication mechanism, provide follow-up project tracking and services, and make every effort to facilitate the implementation of high-quality foreign-invested projects. This will help propel Wuqing's biomedical industry cluster to a higher level and inject strong international innovation momentum into the region's high-quality development.
Source：Wuqing Development Area
Release Time：2025-12-10 12:20:02
Home